5th Annual Update and Advances in Psychiatry Conference - 2017
The Department of Psychiatry, in association with the University of Wisconsin School of Medicine and Public Health and the Office of Continuing Professional Development in Medicine and Public Health are proud to host the 5th Annual Update and Advances in Psychiatry on October 13 - 14, 2017 at the Monona Terrace, Madison, Wisconsin.
Visiting Faculty and Topics
- Advances in our Understanding of the Conceptualization and Treatment of Borderline Personality Disorder: Katharine Nelson, MD - - Vice Chair for Education, Program Director, Psychiatry Residency; Assistant Professor, Department of Psychiatry, University of Minnesota; Minneapolis, MN
- Pharmacogenomics and Treatment of Depression: What Does it Mean for Clinical Practice?; The Pluses and Minuses of Ketamine Treatment for Refractory Depression; Alan F. Schatzberg, MD - Kenneth T. Norris, Jr., Professor, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine; Stanford, CA
- Advances in Integrating Psychotherapeutic and Psychopharmacological Treatment of PTSD: Providing Trauma-Informed Care: Andrés F. Sciolla, MD - Associate Professor of Clinical Psychiatry, Department of Psychiatry & Behavioral Sciences, University of California, Davis; Sacramento, CA
- Pediatric ADHD and Substance Use Disorders: An Intoxicating Combination: Timothy E. Wilens, MD - - Chief, Child and Adolescent Psychiatry, Massachusetts General Hospital; Co-Director of Center for Addiction Medicine, Massachusetts General Hospital; Associate Professor of Psychiatry, Harvard Medical School; Boston, MA
Faculty - University of Wisconsin
School of Medicine and Public Health
- Integrated Care: Providing Psychiatric Consultation in Primary Care: - Ronald J. Diamond, MD - Professor of Psychiatry
- Comprehensive Management of Children & Adolescents with Autism Spectrum Disorders: Brooke R. Kwiecinski, MD - Clinical Assistant Professor of Psychiatry; Child and Adolescent Psychiatry Fellowship Program Director
- From Exercise to St. John’s Wort: Controversies and Challenges in Integrative Treatments for Mental Illness: Claudia L. Reardon, MD - Associate Professor of Psychiatry
- Peripartum Mood Disorders and Substance Use Disorders: Zachary N. Stowe, MD - - Professor of Psychiatry
- Moderator: Ned H. Kalin, MD - Hedberg Professor and Chair of Psychiatry
- Host and Moderator: Art Walaszek, MD - Professor of Psychiatry
- Accreditation Statement: In support of improving patient care, the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
- Credit Designation Statement: The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 9 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Continuing Education Units: The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for .9 continuing education units (CEUs) or 9 hours.
- NEED STATEMENTThis activity is being held in response to mental health professionals’ previous conference evaluations and the need for ongoing continuing medical education for clinicians in the area of psychiatry.
- TARGET AUDIENCEThis activity has been designed to meet the needs of clinicians and other health care professionals who are looking to enhance their knowledge and skills for the care of their patients with mental health issues.
- ELEMENTS OF COMPETENCEThis CE activity has been designed to change learner competence and focuses on the American Board of Medical Specialties areas of medical knowledge and patient care and procedural skills.
- POLICY ON FACULTY AND SPONSOR DISCLOSUREIt is the policy of the Wisconsin–Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made in the activity handout materials.